Invesco Ltd. 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-10 2:09 pm Sale |
2023-07-10 | 13G | Nektar Therapeutics NKTR |
Invesco Ltd. IVZ |
5,535,430 2.900% |
-31,792,043 (-85.17%) |
Filing |
| 2023-02-02 3:19 pm Purchase |
2023-02-02 | 13G | Nektar Therapeutics NKTR |
Invesco Ltd. IVZ |
37,327,473 19.900% |
435,979 (+1.18%) |
Filing |
| 2022-02-11 12:22 pm Purchase |
2022-02-11 | 13G | Nektar Therapeutics NKTR |
Invesco Ltd. IVZ |
36,891,494 20.000% |
1,434,545 (+4.05%) |
Filing |
| 2021-02-12 2:53 pm Purchase |
2021-02-12 | 13G | Nektar Therapeutics NKTR |
Invesco Ltd. IVZ |
35,456,949 19.800% |
3,827,815 (+12.10%) |
Filing |